Cargando…
Dasatinib Inhibits Lung Cancer Cell Growth and Patient Derived Tumor Growth in Mice by Targeting LIMK1
Lung cancer is a leading cause cancer-related death with diversity. A promising approach to meet the need for improved cancer treatment is drug repurposing. Dasatinib, a second generation of tyrosine kinase inhibitors (TKIs), is a potent treatment agent for chronic myeloid leukemia (CML) approved by...
Autores principales: | Zhang, Man, Tian, Jie, Wang, Rui, Song, Mengqiu, Zhao, Ran, Chen, Hanyong, Liu, Kangdong, Shim, Jung-Hyun, Zhu, Feng, Dong, Zigang, Lee, Mee-Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746816/ https://www.ncbi.nlm.nih.gov/pubmed/33344441 http://dx.doi.org/10.3389/fcell.2020.556532 |
Ejemplares similares
-
Targeting LIMK1 with luteolin inhibits the growth of lung cancer in vitro and in vivo
por: Zhang, Man, et al.
Publicado: (2021) -
Xanthohumol Inhibits the Growth of Keratin 18-Overexpressed Esophageal Squamous Cell Carcinoma in vitro and in vivo
por: Yin, Shuying, et al.
Publicado: (2020) -
3-Deoxysappanchalcone Inhibits Skin Cancer Proliferation by Regulating T-Lymphokine-Activated Killer Cell-Originated Protein Kinase in vitro and in vivo
por: Fu, Xiaorong, et al.
Publicado: (2021) -
Honokiol Inhibits Melanoma Growth by Targeting Keratin 18 in vitro and in vivo
por: Liu, Tingting, et al.
Publicado: (2020) -
The Role of p21-Activated Kinases in Cancer and Beyond: Where Are We Heading?
por: Liu, Hui, et al.
Publicado: (2021)